InforMedix may be a relatively new name in the clinical trials arena, but the people and processes behind it lay a foundation built on some of the most respected experience and expertise in pharma. Our technology has passed the scrutiny and gained the support of advisors who have headed major divisions of Merck, Glaxo SmithKline and Novartis. Our manufacturing and verification components tap the most trusted resources in their industries. Our intellectual property has been validated by 15 awarded patents. And our clinical trial achievements have been recognized by peer review in several prestigious journals. Our resume is indeed a strong one.